Skip to main content

Table 4 Sensitivity, specificity, PPV, and NPV of a novel biomarker using the cut-off values of previous studies

From: Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management

Biomarkers

Time (h)

Cuttoff value

Sensitivity of original study

Sensitivity (95% CI)

Specificity (95% CI)

PPV (95% CI)

NPV (95% CI)

TTM Trial, 100% specificity

 Tau

24

874.5

4 (2–6)

7.9 (1.7–21.4)

100 (92.0–100)

100

55.7 (53.4–58.0)

48

148.8

33 (28–38)

27.0 (13.8–44.1)

97.6 (87.4–99.9)

90.9 (57.3–98.7)

60.3 (55.4–65.0)

72

72.7

42 (36–48)

36.1 (20.8–53.8)

97.7 (87.7–99.9)

92.9 (64.1–99.0)

64.6 (58.7–70.1)

 NFL

24

1232

53 (41–64)

36.8 (2.8–54.0)

100 (92.0–100)

100

64.7 (59.0–70.0)

48

1539

65 (55–74)

58.3 (40.8–74.5)

97.6 (87.4–99.9)

95.5 (74.8–99.3)

73.2 (64.9–80.1)

72

1756

64 (53–74)

62.9 (44.9–78.5)

100 (91.8–100)

100

76.8 (68.3–83.6)

 GFAP

24

3425

17 (13–21)

41.2 (24.7–59.3)

100 (92.0–100)

100

68.8 (62.4–74.5)

48

2952

19 (15–24)

46.9 (29.1–65.3)

97.6 (87.4–99.9)

93.8 (67.6–99.1)

70.7 (63.5–77.0)

72

3581

12 (9–17)

48.5 (30.8–66.5)

100 (91.8–100)

100

71.7 (664.5–77.9)

 UCH-L1

24

12,175

4 (2–7)

2.6 (0.1–13.5)

100 (92.0–100)

100

53.7 (52.4–54.9)

48

7945

9 (6–12)

2.7 (0.1–14.2)

100 (91.6–100)

100

53.9 (52.5–55.2)

72

9170

1 (0–3)

0 (0–9.7)

100 (91.8–100)

 

54.4 (54.4–54.4)

COMACARE Trial, 99% specificity

 Tau

0

206

0

12.2 (4.6–24.8)

97.5 (86.8–99.9)

85.7 (43.0–98.0)

47.6 (44.7–50.5)

24

40

21 (8–34)

34.2 (19.6–51.4)

95.5 (84.5–99.4)

86.7 (61.0–96.4)

62.7 (57.0–68.1)

48

16

75 (61–89)

51.4 (34.4–68.1)

90.5 (77.4–97.3)

82.6 (64.0–92.7)

67.9 (59.9–74.9)

72

10

88 (77–99)

69.4 (51.9–83.7)

95.4 (84.2–99.4)

92.6 (76.1–98.0)

78.9 (69.4–86.0)

 NFL

24

127

78 (65–92)

81.6 (65.7–92.3)

70.5 (54.8–83.2)

70.5 (59.6–79.4)

81.6 (68.8–89.9)

48

263

83 (71–96)

83.3 (67.2–93.6)

88.1 (74.4–96.0)

85.7 (72.2–93.2)

86.1 (74.7–92.8)

72

344

85 (73–97)

85.7 (69.7–95.2)

93.0 (80.9–98.5)

90.9 (76.9–96.8)

88.9 (78.0–94.8)

 GFAP

0

3330

0

17.0 (7.7–30.8)

100 (91.2–100)

100

50.6 (47.4–53.9)

24

8018

13 (2–24)

32.4 (17.4–50.5)

100 (92.0–100)

100

65.7 (60.3–70.7)

48

6262

19 (7–32)

43.8 (26.4–62.3)

97.6 (87.4–99.9)

93.3 (66.0–99.0)

69.5 (62.6–75.7)

72

4235

29 (14–45)

48.5 (30.8–66.5)

100 (91.8–100)

100

71.7 (64.5–77.9)

  1. PPV positive predictive value, NPV negative predictive value, NSE neuron specific enolase, S100-B S100 calcium-binding protein, NFL neurofilament light chain, GFAP glial fibrillary acidic protein, UCHL1 ubiquitin C-terminal hydrolase-L1